| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014615468 |
| P356 | DOI | 10.1186/1475-2840-6-19 |
| P932 | PMC publication ID | 1976604 |
| P698 | PubMed publication ID | 17651487 |
| P5875 | ResearchGate publication ID | 6188199 |
| P2093 | author name string | Beatriz D Schaan | |
| Rogério Sarmento-Leite | |||
| Alexandre S Quadros | |||
| Giuseppe De Lucca | |||
| Marcello Bertoluci | |||
| Alexandra Bender | |||
| P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| Inflammation in atherosclerosis | Q29547428 | ||
| TGF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cells | Q32062998 | ||
| Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta | Q34124569 | ||
| Growth factor expression in aorta of normotensive and hypertensive rats | Q34571323 | ||
| Transforming growth factor-beta in disease: the dark side of tissue repair | Q35603155 | ||
| Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions | Q35607475 | ||
| Disruption of TGF-β signaling in T cells accelerates atherosclerosis | Q36524547 | ||
| Transforming growth factor beta1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis | Q41136241 | ||
| Age-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; population study of serum TGF-beta 1 level in Japanese | Q41847002 | ||
| Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy | Q42170800 | ||
| Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. | Q43794492 | ||
| Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial | Q44459441 | ||
| Relationship between cytokine levels and coronary artery disease in women. | Q51543405 | ||
| Circulating transforming growth factor beta 1 and coronary artery disease. | Q51575463 | ||
| Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients | Q57006561 | ||
| ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary | Q58975787 | ||
| Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury | Q67599810 | ||
| Effects of transforming growth factor-beta 1 on growth of aortic smooth muscle cells. Influences of interaction with growth factors, cell state, cell phenotype, and cell cycle | Q67973785 | ||
| The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-beta | Q71518482 | ||
| Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells | Q71543622 | ||
| The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis | Q71802733 | ||
| Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries | Q73083032 | ||
| Altered plasma levels of cytokines in patients with ischemic heart disease | Q73544157 | ||
| The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease | Q74341199 | ||
| Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease | Q74492477 | ||
| Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus | Q74605614 | ||
| Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1? | Q77748220 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 19 | |
| P577 | publication date | 2007-07-25 | |
| P1433 | published in | Cardiovascular Diabetology | Q2468083 |
| P1476 | title | 'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease | |
| P478 | volume | 6 |
| Q36294234 | Circulating TGF-β1, glycation, and oxidation in children with diabetes mellitus type 1. |
| Q33890498 | Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling |
| Q50452526 | Computational model of collagen turnover in carotid arteries during hypertension. |
| Q34076151 | Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study |
| Q33676034 | Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study |
| Q45077001 | Mathematical modeling of collagen turnover in biological tissue |
| Q38778704 | Oleic acid activates MMPs up-regulation through SIRT1/PPAR-γ inhibition: a probable linkage between obesity and coronary arterial disease |
| Q47109401 | Rutin inhibits coronary heart disease through ERK1/2 and Akt signaling in a porcine model |
| Q35095828 | Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease |
Search more.